Showing results (851-860 of 1,350) with videos related to

Sort By:
Pageof 135
Journal of the American Chemical Society|February 1, 2019
Electrochemical Fragmentation of Cu<sub>2</sub>O Nanoparticles Enhancing Selective C-C Coupling from CO<sub>2</sub> Reduction ReactionHyejin Jung, Si Young Lee, Chan Woo Lee, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 18, 2012
A Novel Herbal Medicine KIOM-MA Exerts an Anti-Inflammatory Effect in LPS-Stimulated RAW 264.7 Macrophage CellsYou-Chang Oh, Won-Kyung Cho, Yun Hee Jeong, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|August 25, 2020
Molecular and Serological Investigation of Severe Fever with Thrombocytopenia Syndrome Virus in CatsJun-Gu Kang, Yoon-Kyung Cho, Sun-Woo Han, et al.
European Journal of Gastroenterology & Hepatology|March 24, 2012
Incidence and 30-day mortality of peptic ulcer bleeding in KoreaSeungJin Bae, Nayoung Kim, Jung Mook Kang, et al.
The Korean Journal of Internal Medicine|March 15, 2017
Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapyYoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumorWon-Kyung Cho, Young Rim Seong, Yeune Hee Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2021
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancerHan Gyul Yoon, Dongryul Oh, Jae Myoung Noh, et al.
Bioresource Technology|July 8, 2017
Biohydrogen production from food waste: Current status, limitations, and future perspectivesYeo-Myeong Yun, Mo-Kwon Lee, Seong-Won Im, et al.
Journal of Gynecologic Oncology|June 16, 2021
Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse featuresNalee Kim, Won Park, Won Kyung Cho, et al.
Cancer Research and Treatment|February 25, 2016
East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)Keunchil Park, Joo-Hang Kim, Eun Kyung Cho, et al.
Pageof 135